Status
ACTIVE
Global HQ
Stockholm, Sweden
Countries of investment
- Sweden
- Switzerland
- Denmark
- USA
- Norway
- Germany
- France
- Finland
- Belgium
- Canada
- Ireland
- United Kingdom
- Netherlands
Investment stages
- Pre-Seed
- Seed
- Series A
- Series B
- Series C
Industries
- Health Tech
- Sustainable Energy
- Biotechnology
- Digital Health
- Medical Devices
- Therapeutics
About
HealthCap is a premier European venture capital firm dedicated to advancing life sciences innovation. Since its inception in 1996, the firm has successfully invested over EUR 1.2 billion in pioneering companies that address significant unmet medical needs and develop transformative therapies. HealthCap's extensive expertise and strategic approach empower entrepreneurs to navigate the complexities of the healthcare landscape, fostering breakthroughs that enhance patient outcomes. With a strong commitment to supporting visionary founders, HealthCap continues to be at the forefront of driving impactful change in the life sciences sector.
HealthCap is a premier European venture capital firm dedicated to advancing life sciences innovation. Since its inception in 1996, the firm has successfully invested over EUR 1.2 billion in pioneering companies that address significant unmet medical needs and develop transformative therapies. HealthCap's extensive expertise and strategic approach empower entrepreneurs to navigate the complexities of the healthcare landscape, fostering breakthroughs that enhance patient outcomes. With a strong commitment to supporting visionary founders, HealthCap continues to be at the forefront of driving impactful change in the life sciences sector.
Investment Thesis
HealthCap invests in life sciences, focusing on diseases with a high unmet medical need and breakthrough therapies that can transform clinical practice and change patients lives.
Manager's Experience
With a strong track record in healthcare investments, the fund manager has successfully executed over 50 deals across Europe and North America. Their strategic focus encompasses late-stage growth and buyout opportunities, emphasizing innovative companies that deliver high-impact solutions. Notable exits have included several market leaders, showcasing a data-driven approach that prioritizes operational excellence. This manager's expertise in navigating complex market dynamics positions them uniquely to capitalize on emerging trends in the health sector.
Team
Staffan Lindstrand
MA£Â¥Rten Steen
Keith Underwood
Johan Christenson
Jacob Gunterberg
Gunilla Bystrom
Georg Beiske
Fabrice Bernhard
Car
Carl Kilander